 Last Friday, health care focused hedge fund M28 Capital filed a 13DA with the US Securities Exchange Committee revealing it bought 2.85 million Adagio Therapeutics US:ADGI at an average of 4.28 per share, bringing its holding to 9.2 million, or 8.5 of the company. 